Clinical trial

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in…

NCT00081094 · Washington University School of Medicine, Other · Completed

Key facts

NCT number NCT00081094
Title Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
Official title Detection of Hepatocellular Carcinoma by Positron Emission Tomography With C-Acetate-11 and F-fluorodeoxyglucose-18
Lead sponsor Washington University School of Medicine, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Liver Cancer
Intervention type Procedure
Interventions 18F-Fluorodeoxyglucose-PET (FDG-PET), 11Carbon-Acetate-PET
Enrollment 31
Start date Sep 1, 2003
Primary completion Jun 1, 2005
Completion Sep 1, 2005
First posted Apr 8, 2004
Last update posted Apr 23, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies